Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 59.76
+0.48 (0.81%)
Apr 17, 2026, 3:04 PM CST
SHE:300841 Market Cap
SHE:300841 has a market cap or net worth of 7.7 billion as of April 17, 2026. Its market cap has increased by 1.26% in one year.
Market Cap
7.70B
Enterprise Value
6.91B
Revenue
1.21B
Ranking
n/a
PE Ratio
42.36
Stock Price
59.76
Market Cap Chart
Since June 16, 2020, SHE:300841's market cap has increased from 6.08B to 7.70B, an increase of 26.70%. That is a compound annual growth rate of 4.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 7.70B | -17.96% |
| Dec 31, 2025 | 9.39B | 34.30% |
| Dec 31, 2024 | 6.99B | -32.58% |
| Dec 29, 2023 | 10.37B | -8.37% |
| Dec 30, 2022 | 11.32B | -40.88% |
| Dec 31, 2021 | 19.14B | -31.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Aidea Pharmaceutical Group | 8.63B |
| Zhejiang Ausun Pharmaceutical | 8.49B |
| Acrobiosystems | 8.42B |
| Daan Gene | 8.39B |
| Nanjing Vazyme Biotech | 7.78B |
| GemPharmatech | 7.74B |
| Suzhou Fengbei Biotech Stock | 7.70B |
| Anhui Huaheng Biotechnology | 7.06B |